Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China.
Department of Inspection, Medical Faculty of Qingdao University, Qingdao, China.
Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):1. doi: 10.1167/iovs.63.13.1.
The purpose of this study was to identify a new candidate gene for keratoconus and congenital cataracts and further investigate its underlying pathogenic mechanisms.
This study, using a Chinese family with keratoconus and congenital cataracts, 262 patients with sporadic keratoconus, and 20 patients with sporadic congenital cataract as subjects, used clinical and genetic analysis and in vitro cell experiments to detect genetic mutations and further investigate the underlying pathogenic mechanisms.
We found that a novel frameshift mutation of ERCC8 (NM_000082.3: c.394-398del, p. L132Nfs*6) is responsible for familial keratoconus with congenital cataracts. This mutation showed co-segregation with the phenotype in the family. This was revealed in another patient with sporadic keratoconus, absent in the 210 unrelated health controls, and considered to be "disease-causing." ERCC8 was expressed both in the cornea and lens. Through an in vitro cell experiment, we further demonstrated that the mutant proteins of ERCC8 were degraded and could lead to an insufficient dose of the ERCC8 protein. An insufficient dose reduced the DNA damage repair ability of human corneal fibroblast (HTK) and lens epithelial cells (HLEC) treated with hydrogen peroxide, leading to both cells showing higher DNA damage levels. In addition, it decreased cell viability, resulting in decreased collagen expression in HTK and increased apoptosis in HLEC via aberrant activation of the unfolded protein response. All these results suggested that ERCC8 plays an important role in the normal function of corneal stromal and lens epithelial cells.
Our study showed that ERCC8 is a new gene associated with keratoconus and congenital cataracts.
Chinese Abstract.
本研究旨在鉴定圆锥角膜和先天性白内障的新候选基因,并进一步探讨其潜在的发病机制。
本研究以一个患有圆锥角膜和先天性白内障的中国家系、262 例散发型圆锥角膜患者和 20 例散发型先天性白内障患者为研究对象,采用临床和遗传学分析及体外细胞实验,检测基因突变,并进一步探讨其潜在的发病机制。
我们发现 ERCC8(NM_000082.3:c.394-398del,p. L132Nfs*6)的一个新的移码突变是导致家族性圆锥角膜伴先天性白内障的原因。该突变在家系中与表型共分离。在另一位散发型圆锥角膜患者中也发现了该突变,而在 210 名无关健康对照中则不存在,该突变被认为是“致病的”。ERCC8 在角膜和晶状体中均有表达。通过体外细胞实验,我们进一步证实 ERCC8 的突变蛋白被降解,导致 ERCC8 蛋白的剂量不足。剂量不足降低了人角膜成纤维细胞(HTK)和晶状体上皮细胞(HLEC)经过氧化氢处理后的 DNA 损伤修复能力,导致两种细胞的 DNA 损伤水平均升高。此外,它还降低了细胞活力,导致 HTK 中胶原表达减少,HLEC 中通过未折叠蛋白反应的异常激活导致凋亡增加。所有这些结果表明,ERCC8 在角膜基质和晶状体上皮细胞的正常功能中发挥重要作用。
本研究表明,ERCC8 是一个与圆锥角膜和先天性白内障相关的新基因。